<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPathology</journal-id><journal-title-group><journal-title>Open Journal of Pathology</journal-title></journal-title-group><issn pub-type="epub">2164-6775</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojpathology.2023.131005</article-id><article-id pub-id-type="publisher-id">OJPathology-122642</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Primary Digestive Lymphoma: Anatomical, Clinical and Epidemiological Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Razafindrafara</surname><given-names>Herilalao Elisabeth</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Razafimahefa</surname><given-names>Vahatra Joëlle</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rabarison</surname><given-names>Manoahasina Ranaliarinosy</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andriamampionona</surname><given-names>Tsitohery Francine</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Randrianjafisamindrakotroka</surname><given-names>Nantenaina Soa</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Pathology, Hospital Center of Soavinandriana, Antananarivo, Madagascar</addr-line></aff><aff id="aff2"><addr-line>Department of Pathology, Andrainjato University Hospital, Fianarantsoa, Madagascar</addr-line></aff><aff id="aff3"><addr-line>Department of Pathology, Joseph Ravoahangy Andrianavalona University Hospital, Antananarivo, Madagascar</addr-line></aff><pub-date pub-type="epub"><day>30</day><month>11</month><year>2022</year></pub-date><volume>13</volume><issue>01</issue><fpage>46</fpage><lpage>53</lpage><history><date date-type="received"><day>2,</day>	<month>December</month>	<year>2022</year></date><date date-type="rev-recd"><day>26,</day>	<month>January</month>	<year>2023</year>	</date><date date-type="accepted"><day>29,</day>	<month>January</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Gastrointestinal lymphoma is a non-Hodgkin’s lymphoma that develops from MALT (Mucosa Associated Lymphoid Tissue). It is a rare entity representing 1% of tumors of the gastrointestinal tract. In Madagascar, few studies have been performed on these lymphomas. Our objective is to report a series of digestive lymphoma in order to evaluate the epidemiological and anatomical-clinical aspects. This was a retrospective, cross-sectional, descriptive bicentric study conducted at the Department of Pathology at the Soavinandriana Hospital Center (CENHOSOA) and the Department of Pathology at the University Hospital Center of Andrainjato over a period of 4 years from January 1
  <sup>st</sup>, 2016 to December 31
  <sup>st</sup>, 2019. During the study period, we collected 14 cases of primary digestive lymphoma representing 16% of all lymphomas. We noted a female predominance with a sex ratio of 0.75. The mean age of the patients was 35.64 years with extremes of 3 and 78 years. The clinical signs were dominated by occlusive syndrome (57.14%), abdominal pain (21.44%), digestive hemorrhage (7.14%), intestinal invagination (7.14%) and lingual swelling (7.14%). Regarding the location, the ileum was the most frequently affected (42.85%), followed by the stomach (14.29%), the ileo-caecal area (14.29%), the sigmoid (14.29%), the colon (7.14%) and we also noted a lingual location (7.14%). The most frequent histological type was diffuse large B cell lymphoma (42.86%) followed by MALT lymphoma (35.71%), Burkitt’s lymphoma (14.29%) and diffuse small cell lymphoma (unclassified) (7.14%). We did not observe a significant association (p &gt; 0.05) between the site involvement and the histological subtypes. Among the 14 cases, 3 were confirmed by immunohistochemistry. Primary lymphomas of the gastrointestinal tract include several anatomic entities with different presentation and prognosis. Pathological examination is essential for diagnosis. Immunohistochemical examination is a valuable aid for immunophenotyping despite its difficult access in Madagascar. A multidisciplinary collaboration is necessary for an optimal management of these rare lymphomas.
 
</p></abstract><kwd-group><kwd>Lymphoma</kwd><kwd> Gastrointestinal Tract</kwd><kwd> Madagascar</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Gastrointestinal lymphoma is a non-Hodgkin’s lymphoma (NHL) [<xref ref-type="bibr" rid="scirp.122642-ref1">1</xref>] that develops from MALT (Mucosa Associated Lymphoid Tissue) which is a lymphoid tissue attached to the mucosa [<xref ref-type="bibr" rid="scirp.122642-ref2">2</xref>]. Gastrointestinal tract lymphomas are a rare entity [<xref ref-type="bibr" rid="scirp.122642-ref3">3</xref>] comprising only 1% to 4% of all malignant neoplasms of the gastrointestinal tract and it is the most common site of extranodal lymphomas worldwide, accounting for up to 40% of all extranodal non-Hodgkin lymphomas. Primary Gastrointestinal lymphomas are less common, accounting for approximately 10% to 15% of all non-Hodgkin lymphomas [<xref ref-type="bibr" rid="scirp.122642-ref4">4</xref>]. In Madagascar, few studies have been performed on these lymphomas. Our objective is to report a series of digestive lymphoma in order to evaluate the epidemiological and anatomical-clinical aspects.</p></sec><sec id="s2"><title>2. Materials and Method</title><p>This was a retrospective, cross-sectional, descriptive bicentric study conducted at the Department of Pathology at the Soavinandriana Hospital Center (CENHOSOA) and the Department of Pathology at the University Hospital Center of Andrainjato over a period of 4 years from January 1<sup>st</sup>, 2016 to December 31<sup>st</sup>, 2019. We included all cases of digestive lymphoma diagnosed on biopsies (endoscopic or surgical) and on surgical operative parts with anatomopathological confirmation. We excluded incomplete records and did not include suspected gastrointestinal lymphoma lesions without histological or immunohistochemical confirmation and all non-contributory specimens. We studied the following parameters: gender, age, clinical information, lesion topography, and histological subtype. The data were collected in the liaison sheet and the results registers. All specimens were fixed in 10% buffered formalin, processed according to the conventional histological slide preparation technique, and stained with hematoxylin-eosin (HE). We used in some cases immunohistochemistry. The 2008 World Health Organization (WHO) classification was used for histological typing. The analysis was done on Epi info 7.2.2.6 and Microsoft Excel 2020. To investigate the relationship between two variables, we used the Chi-square test with Fisher’s test. Differences were considered significant when “p” was less than 0.05. A descriptive analysis was performed; no other specific statistical tests were performed. A descriptive analysis was performed; no specific statistical test was performed.</p></sec><sec id="s3"><title>3. Results</title><p>During the study period, we collected 14 cases of primary digestive lymphoma, representing 16% of all lymphomas. We noted a female predominance with a sex ratio of 0.75 (<xref ref-type="table" rid="table1">Table 1</xref>). The mean age of the patients was 35.64 years with extremes of 3 and 78 years (<xref ref-type="table" rid="table1">Table 1</xref>). The clinical signs were dominated by occlusive syndrome (57.14%), abdominal pain (21.44%), digestive hemorrhage (7.14%), intestinal invagination (7.14%) and lingual swelling (7.14%). Regarding the location, the ileum (<xref ref-type="fig" rid="fig1">Figure 1</xref>) was the most frequently affected (42.85%), followed by the stomach (14.29%), the ileo-caecal area (14.29%), the sigmoid (14.29%), the colon (7.14%) and we also noted a lingual location (7.14%). The most frequent histological type was diffuse large B cell lymphoma (42.86%) followed by MALT lymphoma (35.71%), Burkitt’s lymphoma (14.29%) and diffuse small cell lymphoma (unclassified) (7.14%). We did not observe a significant association (p &gt; 0.05) between the site involvement and the histological subtypes. Among the 14 cases, 3 were confirmed by immunohistochemistry (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>The primary location of lymphoma in the gastrointestinal tract constitutes 1% to 4% of malignant tumors of the gastrointestinal tract, 10% to 15% of non-Hodgkin’s lymphomas and 30% to 40% of extranodal lymphomas, making the gastrointestinal</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Correlation between age groups and gender</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age Gender</th><th align="center" valign="middle" >&lt;10</th><th align="center" valign="middle" >[10 – 20]</th><th align="center" valign="middle" >[20 – 30]</th><th align="center" valign="middle" >[30 – 40]</th><th align="center" valign="middle" >[40 – 50]</th><th align="center" valign="middle" >[50 – 60]</th><th align="center" valign="middle" >≥60</th></tr></thead><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr></tbody></table></table-wrap><p>tract the most frequent site of extranodal lymphomas [<xref ref-type="bibr" rid="scirp.122642-ref4">4</xref>]. Nevertheless, primary lymphoma of the digestive tract remains a rare entity [<xref ref-type="bibr" rid="scirp.122642-ref3">3</xref>]. Our results are similar with these statements, since lymphoma of the digestive tract represents 16% of all lymphoma cases in both laboratories.</p><p>Regarding gender, our data diverge with those of the literature since we observed a female predominance (<xref ref-type="table" rid="table1">Table 1</xref>) representing 57.14% of cases. On the other hand, authors such as Raina V et al. [<xref ref-type="bibr" rid="scirp.122642-ref5">5</xref>] and Xiang Y et al. [<xref ref-type="bibr" rid="scirp.122642-ref6">6</xref>] have observed a male predominance in their series.</p><p>The mean age was 35.64 years in our study, which is identical to the result of Raina V et al. [<xref ref-type="bibr" rid="scirp.122642-ref5">5</xref>] who found 32 years in their series unlike Xiang Y and al whose mean age was later (63 years) [<xref ref-type="bibr" rid="scirp.122642-ref6">6</xref>]. This difference could be explained by the variation in geographical areas, environmental factors and study populations considered.</p><p>In our series, the presenting signs were mainly dominated by the occlusive syndrome. The results of Shirwaikar Thomas A, performed in Texas, showed that about 45% - 65% of all cases of gastrointestinal lymphoma clinically presented with abdominal pain [<xref ref-type="bibr" rid="scirp.122642-ref7">7</xref>]. These signs could be explained by the fact that digestive lymphoma often presents as a mass that can stenosis or obliterate the digestive lumen explaining the pain and/or obstructive syndrome.</p><p>The site involvement and the histological subtypes have been described as independent prognostic factors in many studies so it is important to determine the pattern of distribution and the various histological subtypes common in one particular region [<xref ref-type="bibr" rid="scirp.122642-ref8">8</xref>].</p><p>In our study, the main location of primary lymphoma of the gastrointestinal tract was the ileum (42.85%) followed by the stomach (14.29%). In their series, Ruskon&#233;-Fourmestraux A et al. [<xref ref-type="bibr" rid="scirp.122642-ref3">3</xref>] and Papaxoinis G et al. [<xref ref-type="bibr" rid="scirp.122642-ref9">9</xref>] reported that the stomach was the primary location of lymphoma.</p><p>The frequency of gastric localization of lymphoma is explained by the pathogenesis of gastric lymphoma of the MALT type with the involvement, in recent years, of a bacterium, Helicobacter pylori. Helicobacter pylori infection induces the formation of a mucosa-associated lymphoid tissue or “MALT” whose evolution can induce a B tumor clone and then lymphoma [<xref ref-type="bibr" rid="scirp.122642-ref10">10</xref>]. In Madagascar, the seroprevalence of Helicobacter pylori infection in adults is 82% [<xref ref-type="bibr" rid="scirp.122642-ref11">11</xref>] but cases of gastric lymphoma remain exceptional. This low rate could be explained by the fact that gastric lymphoma is under-diagnosed in Madagascar due to the difficult access to anatomopathological examination of the majority of patients. Diagnostic difficulties exist. They arise from the fact that biopsy samples are often small and of low quantity. They sometimes contain only undifferentiated areas [<xref ref-type="bibr" rid="scirp.122642-ref12">12</xref>]. A study by Andriamampionona and al on a case of gastric lymphoma showed that the analysis of biopsy fragments showed incomplete dystrophic glandular structures developing on a lymphocytic background and concluded to a gastric adenocarcinoma. A 2/3 gastrectomy with trans-mesocolic gastro-jejunal anastomosis was performed. Histological examination of the surgical specimen revealed a diffuse lymphoid proliferation of large cells, centroblastic and immunoblastic type, associated with some lympho-epithelial lesions, which led to the conclusion of a diffuse large B cell lymphoma [<xref ref-type="bibr" rid="scirp.122642-ref13">13</xref>].</p><p>As for small bowel lymphoma, the involvement of Epstein-Barr virus (EBV) has been described in primary lymphomas of the digestive tract as well as in Burkitt’s lymphoma, often of intestinal or mesenteric location [<xref ref-type="bibr" rid="scirp.122642-ref14">14</xref>]. In our case, the search for EBV in the ileum could not be performed because the technical platform for its realization is not available in Madagascar.</p><p>Some predisposing factors have been incriminated in the development of digestive lymphoma including extensive follicular hyperplasia of the small intestine, immune deficiencies and Helicobacter pylori infection for gastric lymphoma. Radiation therapy, chemotherapy as well as immunosuppressive drugs that are used in inflammatory bowel disease and organ transplantation also play a role [<xref ref-type="bibr" rid="scirp.122642-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.122642-ref16">16</xref>]. In our series, none of these predisposing factors were documented.</p><p>Regarding the histological type of gastrointestinal tract lymphoma, diffuse large B cell lymphoma (<xref ref-type="fig" rid="fig3">Figure 3</xref>) was the main type encountered in our study and that of Juarez-Salcedo LM and al [<xref ref-type="bibr" rid="scirp.122642-ref17">17</xref>]. The majority of authors have found it [<xref ref-type="bibr" rid="scirp.122642-ref18">18</xref>]. The tumor is composed of large B cells of centroblastic type. This proliferation results either from a probable transformation of a marginal zone lymphoma of the MALT or from a large B-cell lymphoma developed in novo in the digestive tract. The distinction between these two forms does not seem to have any therapeutic or prognostic value [<xref ref-type="bibr" rid="scirp.122642-ref14">14</xref>].</p><p>The diagnosis of digestive lymphomas is based on histology from biopsy samples taken during digestive endoscopy or from surgical samples taken during a complication. In our series, biopsy samples were taken in 50% of cases, while ileal resection was performed in 42.86% and ileo-colectomy in 7.14%. The frequency of surgical resection could be explained by the fact that digestive lymphoma was mainly discovered as a complication.</p><p>Regarding to the limitations of our study, our series is not representative of the Malagasy population. Only three of our patients had an immunohistochemical examination due to lack of funds. And Long-term follow-up (evaluation of remission, setback, potential metastasis and mortality) of patients can’t be done in the Madagascar context. Due to lack of resources, only a minority of patients can access appropriate treatment.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Primary lymphomas of the gastrointestinal tract include several anatomic entities with different presentation and prognosis. Clinical symptoms and imaging are not specific. Pathological examination is essential for diagnosis. Immunohistochemical examination is a valuable aid for immunophenotyping despite its difficult access in Madagascar. A multidisciplinary collaboration is necessary for an optimal management of these rare lymphomas.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Elisabeth, R.H., Jo&#235;lle, R.V., Ranaliarinosy, R.M., Francine, A.T. and Soa, R.N. (2023) Primary Digestive Lymphoma: Anatomical, Clinical and Epidemiological Study. Open Journal of Pathology, 13, 46-53. https://doi.org/10.4236/ojpathology.2023.131005</p></sec></body><back><ref-list><title>References</title><ref id="scirp.122642-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Landolsi, A., Chabchoub, I., Limem, S., et al. (2010) Primary Lymphomas of the Digestive Tract (LPTD) in Central Tunisia: Anatomoclinical Study and Therapeutic Results about 153 Cases. Bulletin du Cancer, 97, 435-443. https://doi.org/10.1684/bdc.2010.1085</mixed-citation></ref><ref id="scirp.122642-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Isaacson, P.G. (2005) Update on MALT Lymphomas. Best Practice &amp; Research Clinical Haematology, 18, 57-68. https://doi.org/10.1016/j.beha.2004.08.003</mixed-citation></ref><ref id="scirp.122642-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ruskoné-Fourmestraux</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>Les lymphomes gastriques du MALT</article-title><source> La revue médecine interne</source><volume> 25</volume>,<fpage> 573</fpage>-<lpage>581</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.122642-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Bautista-Quach, M.A., Ake, C.D., Chen, M., et al. (2012) Gastrointestinal Lymphomas: Morphology, Immunophenotype and Molecular Features. Journal of Gastrointestinal Oncology, 3, 209-225.</mixed-citation></ref><ref id="scirp.122642-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Raina, V., Sharma, A., Vora, A., Shukla, N.K., deo, S.V.S. and Damar, R. (2006) Primary Gastrointestinal Non-Hodgkin’s Lymphoma Chemotherapy Alone an Effective Treatment Modality: Experience from a Single Centre in India. Indian Journal of Cancer, 43, Article 30. https://doi.org/10.4103/0019-509X.25773</mixed-citation></ref><ref id="scirp.122642-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Xiang, Y. and Yao, L. (2022) Analysis of 78 Cases of Primary Gastrointestinal Lymphoma. Journal of Healthcare Engineering, 2022, Article ID: 3414302. https://doi.org/10.1155/2022/3414302</mixed-citation></ref><ref id="scirp.122642-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Shirwaikar Thomas, A., Schwartz, M. and Quigley, E. (2019) Gastrointestinal Lymphoma: The New Mimic. BMJ Open Gastroenterology, 6, e000320. https://doi.org/10.1136/bmjgast-2019-000320</mixed-citation></ref><ref id="scirp.122642-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Koch, P., del Valle, F., Berdel, W.E., Willich, N.A., Reers, B., Hiddemann, W., et al. (2001) Primary Gastrointestinal Non-Hodgkin’s Lymphoma: I. Anatomic and Histologic Distribution, Clinical Features, and Survival Data of 371 Patients Registered in the German Multicenter Study GIT NHL 01/92. Journal of Clinical Oncology, 19, 3861-3873. https://doi.org/10.1200/JCO.2001.19.18.3861</mixed-citation></ref><ref id="scirp.122642-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Papaxoinis, G., Papageorgiou, S., Rontogianni, D., Kaloutsi, V., Fountzilas, G., Pavlidis, N., et al. (2006) Primary Gastrointestinal Non-Hodgkin’s Lymphoma: A Clinicopathologic Study of 128 Cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma, 47, 2140-2146.https://doi.org/10.1080/10428190600709226</mixed-citation></ref><ref id="scirp.122642-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Lehours, P. and Mégraud, F. (2005) Infection with Helicobacter Pylori and Gastric Lymphoma of MALT-Type. Antibiotics, 7, 97-105. https://doi.org/10.1016/S1294-5501(05)80174-8</mixed-citation></ref><ref id="scirp.122642-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ramanampamonjy, R.M., Randria, M.J.D., Razafimahefa, S.H., Ratsimandisa, R., Rajaonarivelo, P. and Rajaona, H.R. (2007) Seroprevalence of Helicobacter Pylori Infection in a Malagasy Population Sample. Bulletin de la Société de Pathologie Exotique, 100, 57-60.</mixed-citation></ref><ref id="scirp.122642-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Ruskoné-Fourmestraux, A., Lavergne-Slove, A. and Delmer, A. (2005) Primary Lymphomas of the Digestive Tract. EMC-Hématologie, 2, 259-275.https://doi.org/10.1016/j.emch.2005.10.002</mixed-citation></ref><ref id="scirp.122642-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Andriamampionona, T.F., Razafindrafara, H.E., Randriamavo, S.H., Ranaivomanana, V.F., Rakoto Ratsimba, H.N. and Randrianjafisamindrakotroka, N.S. (2015) Diffuse Large B-Cell Lymphoma of the Stomach: About a Case Report. Revue Tropicale de Chirurgie, 9, 6-8.</mixed-citation></ref><ref id="scirp.122642-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Ruskoné-Fourmestraux, A., Lavergne-Slove, A. and Delmer, A. (2005) Lymphomes primitifs du tube digestif. EMC-Hématologie, 2, 259-275.</mixed-citation></ref><ref id="scirp.122642-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Herrmann, R., Panahon, A.M., Barcos, M.P., et al. (1980) Gastrointestinal Involvement in Non-Hodgkin’s Lymphoma. Cancer, 46, 215-222.https://doi.org/10.1002/1097-0142(19800701)46:1&lt;215::AID-CNCR2820460136&gt;3.0.CO;2-6</mixed-citation></ref><ref id="scirp.122642-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Kyriacou, C., Loewen, R.D., Gibbon, K., et al. (1991) Pathology and Clinical Features of Gastrointestinal Lymphoma in Saudi Arabia. Scottish Medical Journal, 36, 68-74. https://doi.org/10.1177/003693309103600302</mixed-citation></ref><ref id="scirp.122642-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Juarez-Salcedo, L.M., Sokol, L., Chavez, J.C. and Dalia, S. (2018) Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment. Cancer Control, 25, Article ID: 1073274818778256. https://doi.org/10.1177/1073274818778256</mixed-citation></ref><ref id="scirp.122642-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ruskoné-Fourmestraux, A., Fabiani, B., Malamut, G. and Thieblemont, C. (2019) Lymphomes Gastro-Intestinaux. EMC-Hematologie, 14, 1-13.</mixed-citation></ref></ref-list></back></article>